Rising US inflation rate to taper off next year – leading macroeconomic influencers
The rising inflation rate in the US has raised concerns among consumers and experts who...
Analysis
Patent buyouts can ensure equitable access to vaccines – leading macroeconomic influencers
The monopolistic pricing policies of private pharmaceutical companies have hindered the ability of low-income countries...
Why has the WHO asked governments to delay Covid-19 booster jabs?
While booster shots will likely be needed long-term, the WHO has argued that first jabs...
Global economy heading towards stagflation – leading macroeconomic influencers
The global economy is moving towards stagflation witnessed by the rising inflation rates in major...
Will Covid-19 vaccines be approved for young children?
Some vaccine makers are seeking regulatory approval for children younger than 12 years old.
Clover Biopharmaceuticals’ Covid-19 jab could help boost global vaccine supply
The clinical-stage company has announced that its Covid-19 vaccine candidate, SCB-2019, is 67% effective against the virus.
Show us the money: Sustainable finance tech for COP26 to think about
COP26 is likely to bring more power to the net-zero movement. But what changes can sustainable technology bring?
China’s real estate sector slowdown could impact economic recovery – leading macroeconomic influencers
China’s real estate sector slowdown could impact economic recovery – leading macroeconomic influencers
Big pharma fuelling human rights crisis over Covid-19 vaccine inequity, says Amnesty
The human rights group has accused the world’s leading vaccine makers of failing to allocate doses fairly across the globe.
Merck and Ridgeback’s molnupiravir rollout difficult to map in uncertain Covid-19 landscape
Questions about oral molnupiravir's deployment still loom large as clinicians await crucial late-stage trial results.
Inside the $45bn robotics market: The taxonomy and value chain behind today’s robot helpers
The robotics industry was worth $45bn in 2020, and by 2030, it will have grown at a CAGR of 29% to $568bn.
